World's Best Scientists 2026 revealed!

Michael Rosenblum publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael Rosenblum sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

The last bar groups every scientist with 807 publications or more.

Michael Rosenblum D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Rosenblum sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael Rosenblum is affiliated with the University of California, San Francisco in the United States. Their research primarily focuses on immunology and microbiology, with a significant body of work in medicine. The main fields of study covered by Rosenblum's publications include immunology, oncology, dermatology, molecular biology, and surgery.

Their scientific output reflects key topics such as T-cell and B-cell immunology, immune cell function and interaction, immunotherapy and immune responses, CAR-T cell therapy research, dermatology and skin diseases, cancer immunotherapy and biomarkers, and cell adhesion molecules research.

Frequent publication venues for Rosenblum's research include:

  • Science Immunology
  • The Journal of Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Experimental Medicine
  • Journal of Investigative Dermatology

Rosenblum has collaborated regularly with several coauthors, among them Margaret M. Lowe, Jarish N. Cohen, Mariela Pauli, J. Moreau, and Adil Daud.

Recent papers authored or coauthored by Michael Rosenblum demonstrate the scope and focus of research interests:

  • "Dermal Adipocyte Lipolysis and Myofibroblast Conversion Are Required for Efficient Skin Repair," 2020, Cell Stem Cell
  • "Transforming growth factor-β1 in regulatory T cell biology," 2022, Science Immunology
  • "Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer," 2020, Nature Communications
  • "Regulatory T cells in skin injury: At the crossroads of tolerance and tissue repair," 2020, Science Immunology
  • "Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma," 2020, Clinical Cancer Research

Best Publications

  • Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity

    Miranda L. Broz;Mikhail Binnewies;Bijan Boldajipour;Amanda E. Nelson

  • A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.

    Kevin C. Barry;Joy Hsu;Miranda L. Broz;Francisco J. Cueto;Francisco J. Cueto;Francisco J. Cueto

  • Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation

    Niwa Ali;Niwa Ali;Bahar Zirak;Robert Sanchez Rodriguez;Mariela L. Pauli

  • A Wave of Regulatory T Cells into Neonatal Skin Mediates Tolerance to Commensal Microbes

    Tiffany C. Scharschmidt;Kimberly S. Vasquez;Hong-An Truong;Sofia V. Gearty

  • Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma

    Adil I. Daud;Kimberly Loo;Mariela L. Pauli;Robert Sanchez-Rodriguez

  • Mechanisms of human autoimmunity

    Michael D. Rosenblum;Kelly A. Remedios;Abul K. Abbas

  • Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC

    Paul C. Tumeh;Matthew D. Hellmann;Omid Hamid;Katy K. Tsai

  • Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.

    Daniel F Hanley;Karen Lane;Nichol McBee;Wendy Ziai

  • Depleting tumor-specific Tregs at a single site eradicates disseminated tumors

    Aurélien Marabelle;Holbrook Kohrt;Idit Sagiv-Barfi;Bahareh Ajami

  • COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis

    Levi B. Watkin;Birthe Jessen;Wojciech Wiszniewski;Timothy J. Vece

  • Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial

    Nancy S Padian;Ariane van der Straten;Gita Ramjee;Tsungai Chipato

  • Regulatory T cell memory

    Michael D. Rosenblum;Sing Sing Way;Abul K. Abbas

  • Response to self antigen imprints regulatory memory in tissues

    Michael D. Rosenblum;Iris K. Gratz;Jonathan S. Paw;Karen Lee

  • Memory regulatory T cells reside in human skin

    Robert Sanchez Rodriguez;Mariela L. Pauli;Isaac M. Neuhaus;Siegrid S. Yu

  • Cutting Edge: Regulatory T Cells Facilitate Cutaneous Wound Healing.

    Audrey Nosbaum;Nicolas Prevel;Hong-An Truong;Pooja Mehta

  • Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial

    Daniel F. Hanley;Richard E. Thompson;John Muschelli;Michael Rosenblum

  • Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization

    Hsin-Wen Chang;Di Yan;Di Yan;Rasnik Singh;Rasnik Singh;Jared Liu

  • Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity

    David Wang;Jason Quiros;Kelly Mahuron;Chien-Chun Pai

  • Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells.

    Yuxuan Miao;Hanseul Yang;John Levorse;Shaopeng Yuan

  • Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor.

    C. F. LeMaistre;C. Meneghetti;M. Rosenblum;J. Reuben

Frequent Co-Authors

Abul K. Abbas
Abul K. Abbas University of California, San Francisco
Matthew F. Krummel
Matthew F. Krummel University of California, San Francisco
Arlene H. Sharpe
Arlene H. Sharpe Harvard University
Ariane van der Straten
Ariane van der Straten University of California, San Francisco
Daniel J. Campbell
Daniel J. Campbell Virginia Mason Medical Center
Rosemary J. Akhurst
Rosemary J. Akhurst University of California, San Francisco
Johann E. Gudjonsson
Johann E. Gudjonsson University of Michigan–Ann Arbor
Ann Marshak-Rothstein
Ann Marshak-Rothstein University of Massachusetts Chan Medical School
Ramin Mojtabai
Ramin Mojtabai Johns Hopkins University
Elizabeth A. Stuart
Elizabeth A. Stuart Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career pathways in healthcare. Many students begin with foundational programs such as the easy admission LPN programs, which provide quick entry into patient care roles and valuable clinical experience.

Advancing to specialized nursing fields is a common next step. Identifying which nurse practitioner program is easiest to enter can help prospective students balance career goals with program demands, ensuring a smoother transition to advanced practice roles.

For those focused on mental health, pursuing a psychiatric mental health nurse practitioner (PMHNP) credential is highly valuable. Choosing from the best PMHNP programs online ensures strong clinical placements, an essential factor for hands-on learning and job readiness.

Cost is also a critical consideration. Many learners seek the cheapest PMHNP programs online to manage expenses without compromising on educational quality. Overall, these pathways complement immunology studies by broadening healthcare expertise and enhancing career flexibility.

Best Scientists Citing Michael Rosenblum

Trending Scientists

Recently Published Articles